The
Unbridled Greed of the the Drug Industry
The
NYT has uncovered an ugly situation with prescription drugs,
where people are paying far more than they have to to get medicines
that will literally keep them from dying.
It turns out that pharmacy benefits
managers in many case have agreements that forbid pharmacists from
telling customer they could save money by paying for their
prescription rather than going through their insurance co-payment
system.
WASHINGTON
— As consumers face rapidly rising drug costs, states across the
country are moving to block “gag clauses” that prohibit
pharmacists from telling customers that they could save money by
paying cash for prescription drugs rather than using their health
insurance.
Many
pharmacists have expressed frustration about such provisions in their
contracts with the powerful companies that manage drug benefits for
insurers and employers. The clauses force the pharmacists to remain
silent as, for example, a consumer pays $125 under her insurance plan
for an influenza drug that would have cost $100 if purchased with
cash.
Much
of the difference often goes to the drug benefit managers.
Of course the drug benefit managers are
only doing this to protect people, not to gauge them.
In
North Dakota, a new law explicitly bans gag orders. It says that a
pharmacy or pharmacist may provide information that “may include
the cost and clinical efficacy of a more affordable alternative drug
if one is available.”
The
North Dakota law also says that a pharmacy benefit manager or insurer
may not charge a co-payment that exceeds the actual cost of a
medication.
The
lobby for drug benefit companies, the Pharmaceutical Care Management
Association, has filed suit in federal court to block the North
Dakota law, saying it imposes “onerous new restrictions on pharmacy
benefit managers.”
Some states are taking action, but no
one expects a few governments or even the federal government to be
able to turn the tide in favor of decency. The money the lobbyists
have is just too much.
No comments:
Post a Comment